From: Improvement in health-related quality of life in osteoporosis patients treated with teriparatide
Domain | Question | Baseline Mean (SD)-3 Mth patients | Baseline Mean (SD)-6 Mth patients | 3 Month Follow-up (SD) | 6 Month Follow-up (SD) | Sig (2 tailed) 3 Mths | Sig (2 tailed) 6 mths |
---|---|---|---|---|---|---|---|
Symptoms | Q1 | 4.400 (1.850) | 3.911 (1.905) | 3.533 (1.833) | 3.311 (1.607) | 0.028 | 0.039 |
 | Q2 | 4.233 (1.960) | 3.756 (2.112) | 3.967 (1.921) | 3.200 (1.646) | 0.475 | 0.022 |
Emotional Functioning | Q3 | 3.633 (2.141) | 2.800 (2.052) | 3.267 (2.033) | 2.578 (1.948) | 0.102 | 0.488 |
 | Q4 | 3.600 (1.940) | 2.889 (1.886) | 3.000 (2.034) | 2.756 (1.956) | 0.019 | 0.641 |
Physical Functioning | Q5 | 3.933 (2.016) | 3.600 (2.168) | 3.967 (1.903) | 3.267 (2.093) | 0.882 | 0.092 |
 | Q6 | 3.867 (2.080) | 3.267 (2.230) | 3.600 (2.175) | 2.911(2.172) | 0.428 | 0.139 |
ADLs | Q7 | 3.367 (2.632) | 3.133 (2.659) | 2.933 (2.406) | 2.333 (2.558) | 0.227 | 0.036 |
 | Q8 | 3.467 (2.417) | 3.067 (2.416) | 2.967 (2.236) | 2.489 (2.351) | 0.083 | 0.106 |
Leisure | Q9 | 3.100 (2.234) | 2.378 (2.167) | 2.200 (2.091) | 2.244 (1.897) | 0.001 | 0.679 |
 | Q10 | 2.733 (2.586) | 2.333 (2.421) | 2.500 (2.330) | 2.222 (2.245) | 0.415 | 0.628 |